14-day Premium Trial Subscription Try For FreeTry Free
$0.0586
+0.0075 (+14.68%)
At Close: Apr 23, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Tuesday, 23rd Apr 2024 BLPH stock ended at $0.0586. This is 14.68% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 0% from a day low at $0.0586 to a day high of $0.0586.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Nov 28, 2023 $0.0380 $0.0380 $0.0330 $0.0336 14 605
Nov 27, 2023 $0.0350 $0.0390 $0.0330 $0.0330 8 824
Nov 24, 2023 $0.0355 $0.0380 $0.0350 $0.0350 8 727
Nov 22, 2023 $0.0330 $0.0400 $0.0330 $0.0330 72 306
Nov 21, 2023 $0.0325 $0.0372 $0.0325 $0.0330 51 602
Nov 20, 2023 $0.0325 $0.0348 $0.0325 $0.0348 44 056
Nov 17, 2023 $0.0290 $0.0343 $0.0290 $0.0328 29 770
Nov 16, 2023 $0.0370 $0.0370 $0.0325 $0.0330 199 012
Nov 15, 2023 $0.0325 $0.0400 $0.0325 $0.0375 40 139
Nov 14, 2023 $0.0370 $0.0370 $0.0300 $0.0330 234 563
Nov 13, 2023 $0.0360 $0.0375 $0.0325 $0.0348 90 423
Nov 10, 2023 $0.0390 $0.0390 $0.0360 $0.0360 9 734
Nov 09, 2023 $0.0346 $0.0390 $0.0346 $0.0380 19 606
Nov 08, 2023 $0.0400 $0.0400 $0.0340 $0.0354 515 395
Nov 07, 2023 $0.0380 $0.0405 $0.0370 $0.0380 59 745
Nov 06, 2023 $0.0383 $0.0476 $0.0380 $0.0381 83 797
Nov 03, 2023 $0.0380 $0.0476 $0.0380 $0.0390 13 154
Nov 02, 2023 $0.0482 $0.0482 $0.0375 $0.0380 20 096
Nov 01, 2023 $0.0375 $0.0400 $0.0375 $0.0375 34 423
Oct 31, 2023 $0.0382 $0.0382 $0.0375 $0.0375 655
Oct 30, 2023 $0.0370 $0.0450 $0.0370 $0.0375 180 497
Oct 27, 2023 $0.0550 $0.0600 $0.0360 $0.0360 381 471
Oct 26, 2023 $0.0551 $0.0600 $0.0550 $0.0587 344 030
Oct 25, 2023 $0.0550 $0.0575 $0.0532 $0.0550 61 088
Oct 24, 2023 $0.0541 $0.0609 $0.0523 $0.0550 199 383
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT